With the new Falsified Medicines Directive coming into force on 9th February 2019, pharmaceutical companies are now also able to verify and decommission POYC medicines using Shireburn’s own EMVS module at the point-of-sale.
In addition to supporting pharmaceutical clients, ensuring their compliance with the EU Falsified Medicines Directive, Shireburn have extended their support to also handle POYC dispensing.
The inclusion of the POYC functionality will ensure even smoother processing at the Pharmacy and the use of one single software for all FMD compliance processing. Pharmacies will not be required to enter POYC products into their inventory system in order to verify them as the new directive requires.
In addition, the new feature also supports the common practice whereby pharmacies pre-pack the POYC packages for patients.
Shireburn’s EMVS module was launched in December to help pharmaceutical businesses and pharmacies to automate adherence to the new directive. The European Medical Verification System (EMVS) is an initiative to protect the European pharmaceutical supply chain from the entry of falsified medicines and enforces verification of authenticity at the point of supply of all prescription products.
Pharmacies and other local businesses involved in the sale of medicines will need to verify each product at the point of dispensing to the patient. With the help of the new EMVS software module, Shireburn’s inventory and point of sale users will benefit from an automated verification process that involves scanning the barcode of each product as it is being sold, automatically validating it with the Malta Medicines Verification Organisation (MaMVO) as well as managing their stock and cash. Extending this capability to POYC stock further adds value and automation through one single point.
The Shireburn EMVS module is designed to ensure minimum impact on users with one scan, maximum automation and full auditing and ensures minimisation of manual work that would need to be typically done at the point of sale in the absence of an automated and integrated system such as the Shireburn EMVS module.